
Texas judge orders hold on FDA approval of abortion pill, but another ruling contradicts him [Los Angeles Times :: BC-ABORTION-PILL-2ND-LEDE:LA]
- Bias Rating
50% Medium Conservative
- Reliability
50% ReliableAverage
- Policy Leaning
50% Medium Conservative
- Politician Portrayal
-30% Negative
Continue For Free
Create your free account to see the in-depth bias analytics and more.
Continue
Continue
By creating an account, you agree to our Terms and Privacy Policy, and subscribe to email updates. Already a member: Log inBias Score Analysis
The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.
Sentiments
N/A
- Liberal
- Conservative
Sentence | Sentiment | Bias |
---|---|---|
Unlock this feature by upgrading to the Pro plan. |
Reliability Score Analysis
Policy Leaning Analysis
Politician Portrayal Analysis
Bias Meter
Extremely
Liberal
Very
Liberal
Moderately
Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately
Conservative
Very
Conservative
Extremely
Conservative
-100%
Liberal
100%
Conservative

Contributing sentiments towards policy:
63% : Meanwhile, anti-abortion groups rejoiced at the Texas ruling, calling the FDA "reckless" and repeating claims against mifepristone's safety.60% : Kacsmaryk, who has long held anti-abortion views, said the FDA "omitted any evaluation of the psychological effects of the drug or an evaluation of the long-term medical consequences of the drug."
42% : "Abortion is still legal and accessible here in California and we won't stand by as fundamental freedoms are stripped away."
41% : The ruling, which does not go into effect for seven days and is certain to be quickly appealed, could effectively prohibit use of the medication nationwide, including in California and other states where abortion is legal.
35% : Civil rights groups campaigned against Kacsmaryk's nomination, warning that he was an "anti-LGBT activist and culture warrior" who opposed same-sex marriage and abortion rights.
34% : Some supporters of abortion rights have called on the Biden administration and the FDA to ignore Kacsmaryk's ruling, citing the judge's outspoken opposition to abortion and the significant data compiled since mifepristone's approval that show it is safe.
31% : "The judge's decision in Texas today blocking the FDA's approval of mifepristone is an outrage and exposes the weaponization of our judicial system to further restrict abortion nationwide," Alexis McGill Johnson, president and chief executive of Planned Parenthood Federation of America, said in a statement.
18% : As a judge, Kacsmaryk has blocked Biden's plan to reverse Trump's "Remain in Mexico" immigration policy, a ruling that forced tens of thousands of migrants seeking asylum to wait in Mexico for U.S. immigration court hearings.
*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.